Have questions about the economic measures put in place to support businesses affected by the coronavirus (COVID-19)? Visit the Québec.ca.  Ce lien mène à un site qui n'est peut-être pas soumis au standard gouvernemental sur l'accessibilité. website.

Ouvrir ou fermer le menu de navigation

La page est en cours de chargement...  

Bannière Excellence Québec

Québec, your business partner

Among the lowest operating costs in North America

According to KPMG’s Competitive Alternatives 2016.  Ce lien mène à un site qui n'est peut-être pas soumis au standard gouvernemental sur l'accessibilité., not only do Québec’s major cities have some of the lowest operating costs in North America, but they’re also lower than in Europe.

More specifically, Québec City and Montréal have some of the lowest R&D operating costs among major North American metropolitan areas in the life sciences industry.

Substantial government support

The 2017–2027 Québec Life Sciences Strategy

The Government of Québec is in the process of implementing the 2017–2027 Québec Life Sciences Strategy. The strategy is aimed at strengthening Québec’s excellent positioning on the world stage in the life sciences industry and accelerating Québec’s economic growth, while taking full advantage of recent changes in the sector and future opportunities.

The strategy will receive $205 million in funding over the first five years.

Here are some of the key measures to be implemented:

  • $75 million for the Health Collaboration Acceleration Fund
  • $11.1 million to improve clinical research processes
  • $100 million to support private investment projects and turn Québec into a prime location for biomanufacturing projects
  • $26.5 million to implement and support the Health and Social Services Innovation Office
Attractive tax measures

Québec companies involved in the life sciences benefit from:

  • Provincial tax credits of up to 30% of R&D expenses
  • Federal tax credits of up to 35% of R&D expenses

Foreign researchers and experts established in Québec benefit from:

  • Tax holidays of up to five years
Financial support to promote business growth in Québec

The Government of Québec recently announced BioMed Propulsion.  Ce lien mène à un site qui n'est peut-être pas soumis au standard gouvernemental sur l'accessibilité., a new equity loan program. The program has $100 million in funding and is aimed at life science companies established or getting established in Québec. To be eligible, companies must raise three times as much as the requested financial assistance.

In addition to this initiative, companies can also benefit from the Essor program.  Ce lien mène à un site qui n'est peut-être pas soumis au standard gouvernemental sur l'accessibilité., which supports private investment projects. ESSOR covers up to 50% of project costs.

Financial support to promote research and development in Québec

The Government of Québec supports major public/private partnership initiatives, including projects funded by the Partnership Fund for an Innovative, Healthy Québec.

The government confirmed last May that it has earmarked $75 million for the creation of a Health Collaboration Acceleration Fund to directly fund capacity-building initiatives and collaborative projects as part of a public/private partnership, for a total of $150 million.

Projects in key cross-cutting niches, such as precision medicine and big data use in healthcare, will be prioritized in terms of funding, as well as projects addressing health issues targeted by Ministère de la Santé et des Services Sociaux. Three calls for proposals will be made: one in fall 2017, one in winter 2019 and one in spring 2020.

Risk capital for innovative projects

Québec has on average attracted over a third of all Canadian risk capital investments in the life sciences industry in the last three years.

Companies have access to funds such as:

  • Fonds de solidarité FTQ
  • Teralys Capital
  • Sanderling
  • TVM Life Science VII
  • Lumira Capital II
  • Merck Lumira Bioscience Fund
  • GSK Canada Life Sciences Innovation Fund
  • CTI Life Sciences Fund II
  • Emerillon Capital
  • Versant Ventures
  • BDC Capital

AmorChem II, a seed fund dedicated to the industry, will be established with a capitalization of $50 million. The Government of Québec, Merck and Fonds de solidarité FTQ will be co-investors in the new fund, which will support promising projects.

Recent successes
  • ProMetic Life Sciences.  Ce lien mène à un site qui n'est peut-être pas soumis au standard gouvernemental sur l'accessibilité. obtained $25 million in financing in April 2017
  • Modulate Therapeutics obtained $16.5 million in financing from TVM Life Science Ventures VII in February 2016
  • Thrasos.  Ce lien mène à un site qui n'est peut-être pas soumis au standard gouvernemental sur l'accessibilité. completed another financing round in March 2015, raising $26.6 million—In 2012, the Québec company had the most lucrative financing round ever in the Canadian life sciences industry, raising $42.5 million
  • Clementia Pharmaceuticals.  Ce lien mène à un site qui n'est peut-être pas soumis au standard gouvernemental sur l'accessibilité. completed a $60 million mezzanine financing round in 2015
  • enGene.  Ce lien mène à un site qui n'est peut-être pas soumis au standard gouvernemental sur l'accessibilité. completed a $13.5 million financing round in 2015

A strategic location in North America

Pour plus d'information : sciencesdelavie@economie.gouv.qc.ca

 

A large, skilled and qualified workforce

Québec features a range of training programs tailored to industry needs:

  • Thirteen higher education institutions offer life science programs, including four faculties of medicine and two faculties of pharmacy
  • Two engineering schools offer programs specialized in health technology
  • Two Québec universities are ranked among the top 100 in the world in clinical and preclinical trials in health and the life sciences: Université de Montréal and McGill University

Sophisticated programs have allowed Québec to train a competent technical workforce for developing and manufacturing pharmaceutical products.

Here are a few examples:

  • Animal health techniques
  • Biomedical analysis technology
  • Processing and food quality technology
  • Mechanical engineering techniques
  • Chemical engineering techniques
  • Laboratory techniques
  • Chemical processing techniques
  • Pharmaceutical production technology

Last update: November 22 2019

Ministère de l'Économie et de l'Innovation

© Gouvernement du Québec, 2020

Suivez-nous

  • LinkedIn
  • Youtube
  • Instagram